Ignac Imre S.
- Country
- Hungary
- Department
- Kardiologia I. Szakrendeles
Research Overview
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
- ZENITH: A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Data & Insights
Has run more than one trial at 109 of 764 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in the prevention and treatment of stroke and systemic embolism, particularly in patients with atrial fibrillation. Their research focuses on advancing therapeutic approaches for cardiac rhythm disorders and their complications.
- Stroke Prevention
- Atrial Fibrillation Management
- Thrombosis Prevention
Their work extends to evaluating novel anticoagulation strategies for improved patient outcomes.
Cardiac Electrophysiology
The investigator concentrates on understanding and treating cardiac rhythm abnormalities, with particular emphasis on irregular heartbeat conditions and their associated risks.
- Cardiac Arrhythmias
- Heart Rate Management
- Cardiovascular Risk Assessment
Their expertise includes evaluating innovative therapeutic approaches for cardiac rhythm disorders.
Therapeutic Innovation
The investigator's work involves assessing new therapeutic agents for cardiovascular conditions, focusing on comparative effectiveness and safety profiles of different treatment options.
- Novel Anticoagulants
- Comparative Medicine
- Clinical Safety Assessment
Their research encompasses evaluation of bleeding risk management in cardiovascular treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.